Citation Impact
Citing Papers
Acute Phase Proteins with Special Reference to C-Reactive Protein and Related Proteins (Pentaxins) and Serum Amyloid A Protein
1983 Standout
Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival
2012
Serum Biomarker Panels for the Detection of Pancreatic Cancer
2011
Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
1993 StandoutScience
Distinctive serum protein profiles involving abundant proteins in lung cancer patients based upon antibody microarray analysis
2005
Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy
2013
Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin Amyloidosis
2016
Impaired immune and acute-phase responses in interleukin-6-deficient mice
1994 StandoutNatureNobel
Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective Clinical Trial
2015
The Systemic Amyloidoses
1997 Standout
NMR structure of the mouse prion protein domain PrP(121–231)
1996 StandoutNatureNobel
Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease
1991
Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases
2002 StandoutNature
A phase II trial of cyclophosphamide, lenalidomide and dexamethasone in previously treated patients with AL amyloidosis
2012
Trends in day 100 and 2-year survival after auto-SCT for AL amyloidosis: outcomes before and after 2006
2010
Atomic structures of amyloid cross-β spines reveal varied steric zippers
2007 StandoutNature
Amyloid diseases of the heart: current and future therapies
2012
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
1997 Standout
Noninvasive Etiologic Diagnosis of Cardiac Amyloidosis Using 99m Tc-3,3-Diphosphono-1,2-Propanodicarboxylic Acid Scintigraphy
2005
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
2005
Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris
1995 Standout
Heparan sulfate as a therapeutic target in amyloidogenesis: prospects and possible complications
2007
Alzheimer's Disease: The Amyloid Cascade Hypothesis
1992 StandoutScience
Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center.
2013
Prion Protein Isoforms, a Convergence of Biological and Structural Investigations
1995 StandoutNobel
Spontaneous generation of infectious nucleating amyloids in the transmissible and nontransmissible cerebral amyloidoses
1994 Nobel
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Antibodies to human serum amyloid P component eliminate visceral amyloid deposits
2010 Nature
Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component
2015
Aspects on human amyloid forms and their fibril polypeptides
2005
Protein folding and misfolding
2003 StandoutNature
Senile Systemic Amyloidosis Presenting With Heart Failure
2005
Mutant prion proteins in Gerstmann-Sträussler-Scheinker disease with neurofibrillary tangles
1992 StandoutNobel
Immunophenotype of neoplastic plasma cells in AL amyloidosis
2009
Structural Typing of Systemic Amyloidoses by Luminescent-Conjugated Polymer Spectroscopy
2009
The Structure of Amyloid Fibrils by Electron Microscopy and X-Ray Diffraction
1997
Cross-Seeding and Cross-Competition in Mouse Apolipoprotein A-II Amyloid Fibrils and Protein A Amyloid Fibrils
2007
Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy
2003
Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloidoses
1989
Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease
1995
Systemic amyloidosis
2015 Standout
Iodine-123 metaiodobenzylguanidine scintigraphic analysis of myocardial sympathetic innervation in patients with AL (primary) amyloidosis
2002
Fantasy of a “Virus” from the Inorganic World: Pathogenesis of Cerebral Amyloidoses by Polymer Nucleating Agents and/or “Viruses”
1989 Nobel
A matched comparison of cyclophosphamide, bortezomib and dexamethasone (CVD) versus risk-adapted cyclophosphamide, thalidomide and dexamethasone (CTD) in AL amyloidosis
2014
Transmissible and non-transmissible amyloidoses: autocatalytic post-translational conversion of host precursor proteins to β-pleated sheet configurations
1988 Nobel
Association of melphalan and high-dose dexamethasone is effective and well tolerated in patients with AL (primary) amyloidosis who are ineligible for stem cell transplantation
2003
Bortezomib and dexamethasone consolidation following risk-adapted melphalan and stem cell transplantation for patients with newly diagnosed light-chain amyloidosis
2012
Organic ion imaging of biological tissue with secondary ion mass spectrometry and matrix‐assisted laser desorption/ionization
2001
The Amyloid State of Proteins in Human Diseases
2012 Standout
Sustained pharmacological depletion of serum amyloid P component in patients with systemic amyloidosis
2010
Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
2015 StandoutNature
AA amyloidosis: basic knowledge, unmet needs and future treatments
2012
Refinement in patient selection to reduce treatment-related mortality from autologous stem cell transplantation in amyloidosis
2012
Cell-free Formation of RNA Granules: Low Complexity Sequence Domains Form Dynamic Fibers within Hydrogels
2012 Standout
Evaluation of Systemic Amyloidosis by Scintigraphy with123I-Labeled Serum Amyloid P Component
1990
Evaluation and Management of the Cardiac Amyloidosis
2007
Noninvasive diagnosis of biopsy-proven cardiac amyloidosis
2004
Evidence for increased amyloid enhancing factor activity in Alzheimer brain extract
1988
Acute-Phase Proteins and Other Systemic Responses to Inflammation
1999 Standout
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
1994 Standout
The Evolution of Gene Expression, Structure and Function of Transthyretin
1997
Technetium pyrophosphate myocardial uptake and peripheral neuropathy in a rare variant of familial transthyretin (TTR) amyloidosis (Ser23Asn): a case report and literature review
2011
Molecular Mechanisms of Amyloidosis
2003 Standout
Transthyretin is an inhibitor of monocyte and endothelial cell interleukin-1 production
1992
Myocarditis
2009 Standout
Soluble amyloid precursor protein (APP) regulates transthyretin and Klotho gene expression without rescuing the essential function of APP
2010 StandoutNobel
The Free Radical Theory of Aging
2003
Scrapie prions aggregate to form amyloid-like birefringent rods
1983 StandoutNobel
A Fluorogenic Aryl Fluorosulfate for Intraorganellar Transthyretin Imaging in Living Cells and in Caenorhabditis elegans
2015 StandoutNobel
Effect of Ions on the Structure of Water: Structure Making and Breaking
2009 Standout
Diagnosis and Management of the Cardiac Amyloidoses
2005
Long-term quantitative evaluation of liver transplantation in familial amyloid polyneuropathy (Portuguese V30M)
2002
Isolation of Low‐Molecular‐Weight Proteins from Amyloid Plaque Fibers in Alzheimer's Disease
1986
Biochemical nature and cellular origin of amyloid enhancing factor (AEF) as determined by anti-AEF antibody.
1988
New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes
2012
Water as an Active Constituent in Cell Biology
2007 Standout
Safety and efficacy of risk-adapted cyclophosphamide, thalidomide, and dexamethasone in systemic AL amyloidosis
2006
ISOLATION OF AMYLOID P COMPONENT (PROTEIN AP) FROM NORMAL SERUM AS A CALCIUM-DEPENDENT BINDING PROTEIN
1977 Standout
Purification and structural studies of a major scrapie prion protein
1984 StandoutNobel
An Increased Percentage of Long Amyloid β Protein Secreted by Familial Amyloid β Protein Precursor (βApp 717 ) Mutants
1994 StandoutScience
Amyloid Deposition in a Renal Transplant in Familial Mediterranean Fever
1977
Ultrastructural morphology of amyloid fibrils from neuritic and amyloid plaques
1983
Current Trends in Diagnosis and Management of Cardiac Amyloidosis
2013
Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Aβ toxicity
2008
High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study
2004
Copper Homeostasis and Neurodegenerative Disorders (Alzheimer's, Prion, and Parkinson's Diseases and Amyotrophic Lateral Sclerosis)
2006 Standout
Human serum amyloid P component is an invariant constituent of amyloid deposits and has a uniquely homogeneous glycostructure.
1994
Characterization of amyloid fibril proteins from medullary carcinoma of the thyroid.
1976
Cerebral amyloid angiopathy in the aged
1987
Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.
1993 Standout
Serum Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic Amyloidosis
2004
Prion protein (PrP) synthetic peptides induce cellular PrP to acquire properties of the scrapie isoform.
1995 StandoutNobel
Prions and prion proteins 1
1991 StandoutNobel
Efficacy and safety of once-weekly and twice-weekly bortezomib in patients with relapsed systemic AL amyloidosis: results of a phase 1/2 study
2011
Amyloid Deposits and Amyloidosis
1980 Standout
Infusion of Light Chains From Patients With Cardiac Amyloidosis Causes Diastolic Dysfunction in Isolated Mouse Hearts
2001
Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis.
1995
Inflammation and Atherosclerosis
2002 Standout
IMMUNOLOGIC STUDIES OF THE MAJOR NONIMMUNOGLOBULIN PROTEIN OF AMYLOID
1973
Uncertain Value of Urinary Sediments in the Diagnosis of Amyloidosis
1977
Autologous stem cell transplantation for primary systemic amyloidosis
2002
Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin T assay
2010
The Hofmeister effect and the behaviour of water at interfaces
1985
Amyloid Deposits and Amyloidosis
1980
C-REACTIVE PROTEIN FIFTY YEARS ON
1981
Field-Deployable, High-Resolution, Time-of-Flight Aerosol Mass Spectrometer
2006 Standout
A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis
2014
In vitro formation of amyloid fibrils from two synthetic peptides of different lengths homologous to alzheimer's disease β-protein
1986
Prions
1998 StandoutNobel
Aromatic Sulfonyl Fluorides Covalently Kinetically Stabilize Transthyretin to Prevent Amyloidogenesis while Affording a Fluorescent Conjugate
2013 StandoutNobel
Recent advances in the treatment of familial amyloid polyneuropathy
2012
Mass Spectrometry Sampling Under Ambient Conditions with Desorption Electrospray Ionization
2004 StandoutScience
Alveolar hydatid cyst induced amyloid enhancing factor (AEF): physicochemical properties and abolition of AEF activity by serine protease inhibitors.
1988
Light chain deposition disease derived from the kappa I light chain subgroup. Biochemical characterization.
1989
Weekly and twice-weekly bortezomib in patients with systemic AL amyloidosis: results of a phase 1 dose-escalation study
2009
Rapid Method to Characterize Mutations in Transthyretin in Cerebrospinal Fluid from Familial Amyloidotic Polyneuropathy Patients by Use of Matrix-assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry
2000
Senile dementia of the Alzheimer type
1983
Amyloidosis
1978
Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met30) gene. Pathologic similarity to human familial amyloidotic polyneuropathy, type I.
1991
Alzheimer's Disease: Cell-Specific Pathology Isolates the Hippocampal Formation
1984 StandoutScience
Amyloid of human islets of Langerhans
1977
RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
1996 StandoutNature
Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing
1992 StandoutScience
Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**
2021 StandoutNobel
Protein A-gold immunoelectron microscopic study of amyloid fibrils, granular deposits, and fibrillar luminal aggregates in renal amyloidosis.
1990
Molecular Biology of Prion Diseases
1991 StandoutScienceNobel
Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome
2013
Evaluating the binding selectivity of transthyretin amyloid fibril inhibitors in blood plasma
2001
Some Speculations about Prions, Amyloid, and Alzheimer's Disease
1984 StandoutNobel
“Inverse Drug Discovery” Strategy To Identify Proteins That Are Targeted by Latent Electrophiles As Exemplified by Aryl Fluorosulfates
2017 StandoutNobel
Prion protein preamyloid and amyloid deposits in Gerstmann-Sträussler-Scheinker disease, Indiana kindred.
1992 StandoutNobel
Guam Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Linked to a Plant Excitant Neurotoxin
1987 StandoutScience
Purified prion proteins and scrapie infectivity copartition into liposomes.
1987 StandoutNobel
[481 Electrophoretic analysis of acute-phase plasma proteins
1988
99m Tc-Pyrophosphate Scintigraphy for Differentiating Light-Chain Cardiac Amyloidosis From the Transthyretin-Related Familial and Senile Cardiac Amyloidoses
2013
The activity of lenalidomide with or without dexamethasone in patients with primary systemic amyloidosis
2006
Works of M Skinner being referenced
Amyloid P-component (protein AP) in localized amyloidosis as revealed by an immunocytochemical method
1981
Serum free light-chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis
2005
High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial
2003
The diflunisal trial: update on study drug tolerance and disease progression
2011
An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis
2001
Identification of a novel substitution in the constant region of a gene coding for an amyloidogenic κ1 light chain
1999
The carbohydrate composition of human serum amyloid P component
1988
Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis
2012
Mobilized CD34+ cells selected as autografts in patients with primary light‐chain amyloidosis: rationale and application
1998
Tandem cycles of high-dose melphalan and autologous stem cell transplantation increases the response rate in AL amyloidosis
2007
Familial amyloidotic polyneuropathy: a new transthyretin position 30 mutation (alanine for valine) in a family of German descent
1992
Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation
1996
Hepatic response after high-dose melphalan and stem cell transplantation in patients with AL amyloidosis associated liver disease
2009
The changing face of AA amyloidosis: a single center experience
2011
AL amyloidosis associated with B‐cell lymphoproliferative disorders: Frequency and treatment outcomes
2006
Clinical features and survival in senile systemic amyloidosis: comparison to familial transthyretin cardiomyopathy
2011
Regression of cardiac wall thickness following chemotherapy and stem cell transplantation for light chain (AL) amyloidosis
2011
Amyloidogenic and non‐amyloidogenic transthyretin Asn 90 variants
1992
Nephelometric measurement of human serum prealbumin and correlation with acute-phase proteins CRP and SAA: results in familial amyloid polyneuropathy.
1984
Acute‐Phase Proteins or Tumour Markers: The Role of SAA, SAP, CRP and CEA as Indicators of Metastasis in a Broad Spectrum of Neoplastic Diseases
1984
Murine amyloid protein AA in casein-induced experimental amyloidosis.
1977
Further characterization of amyloid-enhancing factor.
1982
Immunocytochemical identification of amyloid in formalin-fixed paraffin sections
1981
Characterization of Transthyretin Mutants from Serum Using Immunoprecipitation, HPLC/Electrospray Ionization and Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry
1998
The P‐Component of Amyloid of Human Islets of Langerhans
1975
Senile cerebral amyloid. Prealbumin as a common constituent in the neuritic plaque, in the neurofibrillary tangle, and in the microangiopathic lesion.
1982
Dose-intensive melphalan with blood stem cell support for the treatment of AL amyloidosis: one-year follow-up in five patients
1996
Antigenic Determinants in Amyloid Deposits
1970 Nature
Amyloidosis: clinical, pathologic, and biochemical characteristics.
1983
Binding of serum amyloid P-component (SAP) by amyloid fibrils.
1979
In vitro formation of amyloid fibrils from intact β2-microglobulin
1985
Different regulatory mechanisms for serum amyloid A and serum amyloid P synthesis by cultured mouse hepatocytes.
1983
Kinetics of serum amyloid protein A in casein-induced murine amyloidosis.
1977
Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation.
1995
Orthotopic liver transplantation for familial amyloidotic polyneuropathy.
1994
Proline at position 36: a new transthyretin mutation associated with familial amyloidotic polyneuropathy.
1991
Familial and primary (AL) cardiac amyloidosis: echocardiographically similar diseases with distinctly different clinical outcomes.
1997